Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cost Sharing | 15 | 2017 | 409 | 2.960 |
Why?
|
Medicare Part D | 10 | 2016 | 355 | 2.420 |
Why?
|
Risk Adjustment | 6 | 2013 | 596 | 1.310 |
Why?
|
Health Maintenance Organizations | 10 | 2016 | 656 | 1.310 |
Why?
|
Insurance Coverage | 10 | 2021 | 1946 | 1.120 |
Why?
|
California | 22 | 2017 | 1436 | 1.090 |
Why?
|
Medicare | 21 | 2017 | 6816 | 1.070 |
Why?
|
Personnel Turnover | 2 | 2017 | 89 | 1.030 |
Why?
|
Delivery of Health Care, Integrated | 10 | 2013 | 950 | 0.980 |
Why?
|
Deductibles and Coinsurance | 5 | 2012 | 315 | 0.940 |
Why?
|
Financing, Personal | 7 | 2012 | 310 | 0.850 |
Why?
|
Health Benefit Plans, Employee | 4 | 2012 | 332 | 0.840 |
Why?
|
Managed Care Programs | 6 | 2017 | 934 | 0.840 |
Why?
|
Medicare Part C | 4 | 2016 | 335 | 0.740 |
Why?
|
Health Knowledge, Attitudes, Practice | 8 | 2012 | 4056 | 0.700 |
Why?
|
Insurance, Health | 8 | 2021 | 2521 | 0.670 |
Why?
|
Insurance, Pharmaceutical Services | 3 | 2008 | 347 | 0.630 |
Why?
|
Office Visits | 3 | 2013 | 594 | 0.610 |
Why?
|
Drug Costs | 5 | 2013 | 1193 | 0.610 |
Why?
|
Health Expenditures | 7 | 2017 | 2386 | 0.610 |
Why?
|
Drugs, Generic | 3 | 2016 | 456 | 0.600 |
Why?
|
Electronic Health Records | 7 | 2015 | 4864 | 0.570 |
Why?
|
Preventive Health Services | 2 | 2012 | 570 | 0.560 |
Why?
|
Insurance Benefits | 2 | 2011 | 186 | 0.550 |
Why?
|
Insurance Selection Bias | 2 | 2012 | 69 | 0.450 |
Why?
|
Emergency Service, Hospital | 7 | 2015 | 7872 | 0.440 |
Why?
|
Patient Compliance | 4 | 2008 | 2693 | 0.440 |
Why?
|
United States | 37 | 2021 | 72896 | 0.430 |
Why?
|
Risperidone | 1 | 2016 | 383 | 0.430 |
Why?
|
Information Seeking Behavior | 1 | 2014 | 116 | 0.430 |
Why?
|
Drug Utilization | 3 | 2008 | 1187 | 0.410 |
Why?
|
Medical Savings Accounts | 1 | 2012 | 34 | 0.400 |
Why?
|
Insurance, Medigap | 2 | 2009 | 20 | 0.390 |
Why?
|
American Recovery and Reinvestment Act | 1 | 2012 | 72 | 0.390 |
Why?
|
Patient Protection and Affordable Care Act | 4 | 2021 | 1188 | 0.380 |
Why?
|
Competitive Medical Plans | 1 | 2011 | 26 | 0.380 |
Why?
|
Choice Behavior | 3 | 2015 | 846 | 0.380 |
Why?
|
Health Planning | 1 | 2012 | 233 | 0.370 |
Why?
|
Antipsychotic Agents | 2 | 2016 | 3076 | 0.370 |
Why?
|
Patient Care | 2 | 2013 | 629 | 0.360 |
Why?
|
Poverty | 3 | 2014 | 2714 | 0.350 |
Why?
|
Fees, Pharmaceutical | 1 | 2009 | 66 | 0.330 |
Why?
|
Health Care Reform | 3 | 2016 | 1258 | 0.330 |
Why?
|
Medically Uninsured | 3 | 2014 | 838 | 0.330 |
Why?
|
Patients | 1 | 2016 | 909 | 0.320 |
Why?
|
Attitude of Health Personnel | 3 | 2014 | 3925 | 0.320 |
Why?
|
Ambulatory Care | 6 | 2012 | 2776 | 0.320 |
Why?
|
Hospitalization | 6 | 2021 | 10803 | 0.300 |
Why?
|
Diabetes Mellitus | 5 | 2015 | 5889 | 0.300 |
Why?
|
Health Status Indicators | 2 | 2011 | 967 | 0.300 |
Why?
|
Quality Improvement | 4 | 2016 | 3845 | 0.290 |
Why?
|
Early Detection of Cancer | 3 | 2017 | 3237 | 0.290 |
Why?
|
Health Care Surveys | 6 | 2016 | 2424 | 0.290 |
Why?
|
Comparative Effectiveness Research | 2 | 2017 | 713 | 0.270 |
Why?
|
Aged | 38 | 2021 | 171178 | 0.270 |
Why?
|
Physician-Patient Relations | 4 | 2010 | 3272 | 0.270 |
Why?
|
Models, Organizational | 1 | 2010 | 548 | 0.270 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3251 | 0.270 |
Why?
|
Patient Care Management | 1 | 2009 | 302 | 0.260 |
Why?
|
Delivery of Health Care | 2 | 2017 | 5368 | 0.260 |
Why?
|
Interviews as Topic | 5 | 2013 | 2741 | 0.250 |
Why?
|
Personal Health Services | 1 | 2005 | 24 | 0.250 |
Why?
|
Mammography | 2 | 2016 | 2423 | 0.250 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1405 | 0.240 |
Why?
|
Prescription Fees | 2 | 2005 | 153 | 0.240 |
Why?
|
Male | 48 | 2017 | 363740 | 0.240 |
Why?
|
Female | 50 | 2017 | 396050 | 0.240 |
Why?
|
Benchmarking | 1 | 2011 | 1054 | 0.240 |
Why?
|
Primary Health Care | 6 | 2016 | 4735 | 0.240 |
Why?
|
Health Care Costs | 4 | 2012 | 3240 | 0.240 |
Why?
|
Patient Care Team | 2 | 2013 | 2513 | 0.240 |
Why?
|
Patient Acceptance of Health Care | 5 | 2014 | 3229 | 0.240 |
Why?
|
Quality of Health Care | 3 | 2015 | 4303 | 0.240 |
Why?
|
Income | 5 | 2014 | 1873 | 0.240 |
Why?
|
Primary Prevention | 1 | 2012 | 1187 | 0.230 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2009 | 698 | 0.230 |
Why?
|
Humans | 69 | 2021 | 765823 | 0.230 |
Why?
|
Attitude to Computers | 1 | 2005 | 196 | 0.230 |
Why?
|
Reimbursement Mechanisms | 1 | 2009 | 672 | 0.220 |
Why?
|
Patient Readmission | 3 | 2015 | 3284 | 0.220 |
Why?
|
Anti-Asthmatic Agents | 1 | 2008 | 572 | 0.210 |
Why?
|
Medical Informatics Applications | 1 | 2005 | 180 | 0.210 |
Why?
|
Drug Prescriptions | 3 | 2011 | 1662 | 0.210 |
Why?
|
Aged, 80 and over | 18 | 2016 | 59506 | 0.200 |
Why?
|
Medical Informatics | 1 | 2009 | 742 | 0.200 |
Why?
|
Health Services | 1 | 2006 | 756 | 0.190 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11506 | 0.170 |
Why?
|
Middle Aged | 28 | 2017 | 223016 | 0.170 |
Why?
|
Adrenal Cortex Hormones | 1 | 2008 | 1881 | 0.160 |
Why?
|
Health Services Accessibility | 3 | 2014 | 5508 | 0.160 |
Why?
|
Educational Status | 3 | 2014 | 2511 | 0.160 |
Why?
|
Socioeconomic Factors | 7 | 2016 | 7840 | 0.160 |
Why?
|
Physicians | 1 | 2017 | 4587 | 0.160 |
Why?
|
Confidence Intervals | 3 | 2013 | 2914 | 0.160 |
Why?
|
Ambulatory Care Facilities | 2 | 2016 | 937 | 0.160 |
Why?
|
Adult | 26 | 2017 | 223055 | 0.160 |
Why?
|
Emergency Medicine | 1 | 2008 | 1221 | 0.150 |
Why?
|
Colonoscopy | 2 | 2017 | 1408 | 0.150 |
Why?
|
Denmark | 2 | 2011 | 774 | 0.150 |
Why?
|
Asthma | 3 | 2016 | 6268 | 0.150 |
Why?
|
Telemedicine | 2 | 2006 | 3106 | 0.150 |
Why?
|
Communication | 4 | 2010 | 3906 | 0.140 |
Why?
|
Chlorofluorocarbons | 1 | 2016 | 12 | 0.140 |
Why?
|
Colorectal Neoplasms | 4 | 2017 | 6960 | 0.140 |
Why?
|
Decision Making | 2 | 2008 | 3955 | 0.130 |
Why?
|
Patient Satisfaction | 3 | 2010 | 3474 | 0.130 |
Why?
|
Annual Reports as Topic | 1 | 2016 | 36 | 0.130 |
Why?
|
Program Evaluation | 2 | 2016 | 2501 | 0.130 |
Why?
|
Nebulizers and Vaporizers | 1 | 2016 | 138 | 0.130 |
Why?
|
Albuterol | 1 | 2016 | 211 | 0.130 |
Why?
|
Physicians, Family | 2 | 2010 | 349 | 0.120 |
Why?
|
Longitudinal Studies | 6 | 2015 | 14745 | 0.120 |
Why?
|
Information Services | 2 | 2006 | 240 | 0.110 |
Why?
|
Logistic Models | 5 | 2012 | 13266 | 0.110 |
Why?
|
Cohort Studies | 6 | 2016 | 41643 | 0.110 |
Why?
|
Medicaid | 2 | 2021 | 2832 | 0.110 |
Why?
|
Emergency Services, Psychiatric | 1 | 2013 | 65 | 0.100 |
Why?
|
Mass Screening | 3 | 2017 | 5445 | 0.100 |
Why?
|
Medication Adherence | 2 | 2016 | 2190 | 0.100 |
Why?
|
Adolescent | 12 | 2016 | 88794 | 0.100 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8039 | 0.100 |
Why?
|
Multivariate Analysis | 4 | 2013 | 12056 | 0.100 |
Why?
|
Comorbidity | 2 | 2021 | 10570 | 0.100 |
Why?
|
Hypertension | 3 | 2011 | 8625 | 0.100 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 715 | 0.100 |
Why?
|
Cost Savings | 1 | 2017 | 903 | 0.100 |
Why?
|
Endocarditis, Bacterial | 1 | 2015 | 434 | 0.090 |
Why?
|
Hypoglycemic Agents | 3 | 2012 | 3107 | 0.090 |
Why?
|
Models, Economic | 1 | 2015 | 716 | 0.090 |
Why?
|
Blood Pressure | 1 | 2007 | 8532 | 0.090 |
Why?
|
Economic Recession | 1 | 2012 | 79 | 0.090 |
Why?
|
Biosurveillance | 1 | 2011 | 16 | 0.090 |
Why?
|
Disease Outbreaks | 2 | 2011 | 1760 | 0.090 |
Why?
|
Costs and Cost Analysis | 2 | 2015 | 1667 | 0.090 |
Why?
|
Unemployment | 1 | 2012 | 211 | 0.090 |
Why?
|
Medical Order Entry Systems | 1 | 2015 | 521 | 0.090 |
Why?
|
Medical Staff | 1 | 2010 | 40 | 0.090 |
Why?
|
Cross-Sectional Studies | 6 | 2010 | 26276 | 0.080 |
Why?
|
Quality Indicators, Health Care | 2 | 2010 | 1805 | 0.080 |
Why?
|
Consumer Health Information | 1 | 2012 | 215 | 0.080 |
Why?
|
Quality Assurance, Health Care | 2 | 2010 | 2169 | 0.080 |
Why?
|
Public Health Informatics | 1 | 2010 | 109 | 0.080 |
Why?
|
Young Adult | 8 | 2016 | 59849 | 0.080 |
Why?
|
Child Health Services | 1 | 2014 | 645 | 0.080 |
Why?
|
Financing, Government | 1 | 2012 | 473 | 0.080 |
Why?
|
Prescription Drugs | 1 | 2015 | 634 | 0.080 |
Why?
|
Health Status | 3 | 2016 | 4084 | 0.070 |
Why?
|
Internet | 2 | 2014 | 3104 | 0.070 |
Why?
|
Certification | 1 | 2011 | 419 | 0.070 |
Why?
|
Hospitals, University | 1 | 2010 | 572 | 0.070 |
Why?
|
Tartrates | 1 | 2007 | 13 | 0.070 |
Why?
|
Taxes | 1 | 2010 | 219 | 0.070 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2011 | 389 | 0.070 |
Why?
|
Sentinel Surveillance | 1 | 2010 | 292 | 0.070 |
Why?
|
Observation | 1 | 2009 | 309 | 0.070 |
Why?
|
Cost Control | 1 | 2010 | 625 | 0.070 |
Why?
|
Adrenergic Antagonists | 1 | 2007 | 25 | 0.070 |
Why?
|
Continuity of Patient Care | 1 | 2014 | 1076 | 0.070 |
Why?
|
Thiazides | 1 | 2007 | 19 | 0.070 |
Why?
|
New York City | 1 | 2010 | 734 | 0.070 |
Why?
|
Patient Preference | 1 | 2015 | 947 | 0.070 |
Why?
|
Professional Role | 1 | 2010 | 314 | 0.070 |
Why?
|
Atenolol | 1 | 2007 | 99 | 0.070 |
Why?
|
Metoprolol | 1 | 2007 | 90 | 0.070 |
Why?
|
Family Practice | 1 | 2009 | 508 | 0.070 |
Why?
|
Propanolamines | 1 | 2007 | 163 | 0.070 |
Why?
|
Sex Distribution | 2 | 2015 | 2268 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2013 | 1510 | 0.070 |
Why?
|
Hypolipidemic Agents | 2 | 2012 | 608 | 0.070 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15645 | 0.070 |
Why?
|
Child, Preschool | 6 | 2016 | 42478 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2016 | 1658 | 0.060 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 614 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 2015 | 2082 | 0.060 |
Why?
|
Carbazoles | 1 | 2007 | 229 | 0.060 |
Why?
|
Efficiency, Organizational | 1 | 2010 | 694 | 0.060 |
Why?
|
Outpatients | 1 | 2013 | 1591 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2012 | 2719 | 0.060 |
Why?
|
Prepaid Health Plans | 1 | 2004 | 9 | 0.060 |
Why?
|
Administration, Inhalation | 1 | 2008 | 1154 | 0.060 |
Why?
|
Poisson Distribution | 1 | 2006 | 508 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2011 | 2350 | 0.060 |
Why?
|
Pharmaceutical Services | 1 | 2006 | 145 | 0.060 |
Why?
|
Self Administration | 1 | 2005 | 386 | 0.060 |
Why?
|
Clinical Competence | 2 | 2010 | 4860 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4257 | 0.060 |
Why?
|
Diuretics | 1 | 2007 | 612 | 0.060 |
Why?
|
Infant | 4 | 2013 | 36375 | 0.050 |
Why?
|
Regression Analysis | 3 | 2012 | 6320 | 0.050 |
Why?
|
Odds Ratio | 2 | 2007 | 9653 | 0.050 |
Why?
|
Population Surveillance | 1 | 2013 | 2595 | 0.050 |
Why?
|
Medical Records Systems, Computerized | 1 | 2009 | 1195 | 0.050 |
Why?
|
Databases, Factual | 4 | 2012 | 8062 | 0.050 |
Why?
|
Computers | 1 | 2005 | 588 | 0.050 |
Why?
|
Patient Discharge | 1 | 2015 | 3461 | 0.050 |
Why?
|
Internal Medicine | 1 | 2009 | 1064 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 2006 | 441 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8698 | 0.050 |
Why?
|
Hospitals | 1 | 2015 | 3887 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2007 | 1238 | 0.050 |
Why?
|
Stroke | 2 | 2015 | 9749 | 0.050 |
Why?
|
Insurance Claim Review | 2 | 2016 | 744 | 0.050 |
Why?
|
Qualitative Research | 1 | 2012 | 3135 | 0.050 |
Why?
|
Child | 6 | 2016 | 80509 | 0.040 |
Why?
|
Space-Time Clustering | 2 | 2011 | 45 | 0.040 |
Why?
|
Age Distribution | 1 | 2006 | 2865 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2007 | 6304 | 0.040 |
Why?
|
Hospital Mortality | 2 | 2015 | 5338 | 0.040 |
Why?
|
Influenza, Human | 1 | 2011 | 1539 | 0.040 |
Why?
|
Time Factors | 4 | 2011 | 40109 | 0.040 |
Why?
|
Health Services Research | 1 | 2006 | 1811 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2007 | 6204 | 0.040 |
Why?
|
Cost of Illness | 1 | 2008 | 1949 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2016 | 21064 | 0.040 |
Why?
|
Length of Stay | 1 | 2011 | 6485 | 0.040 |
Why?
|
Risk Assessment | 2 | 2016 | 24278 | 0.040 |
Why?
|
Health Policy | 1 | 2010 | 2699 | 0.040 |
Why?
|
Registries | 1 | 2013 | 8320 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3247 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2006 | 2033 | 0.030 |
Why?
|
Bipolar Disorder | 1 | 2013 | 5127 | 0.030 |
Why?
|
Soil | 1 | 2016 | 123 | 0.030 |
Why?
|
Attitude to Health | 1 | 2004 | 2019 | 0.030 |
Why?
|
Proxy | 1 | 2016 | 150 | 0.030 |
Why?
|
Heart Failure | 2 | 2011 | 11838 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 5529 | 0.030 |
Why?
|
Mortality | 1 | 2006 | 2910 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2010 | 20131 | 0.030 |
Why?
|
Computers, Handheld | 1 | 2016 | 211 | 0.030 |
Why?
|
Cholesterol, LDL | 2 | 2015 | 2393 | 0.030 |
Why?
|
Schizophrenia | 1 | 2013 | 6970 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2004 | 1448 | 0.030 |
Why?
|
Medical Record Linkage | 1 | 2015 | 286 | 0.030 |
Why?
|
Diagnosis-Related Groups | 1 | 2015 | 445 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 11092 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2006 | 3799 | 0.030 |
Why?
|
Algorithms | 2 | 2011 | 14062 | 0.030 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 318 | 0.030 |
Why?
|
Health Behavior | 1 | 2004 | 2649 | 0.020 |
Why?
|
Sex Factors | 2 | 2015 | 10607 | 0.020 |
Why?
|
SEER Program | 1 | 2015 | 1444 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2015 | 933 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2015 | 1166 | 0.020 |
Why?
|
Minnesota | 1 | 2010 | 336 | 0.020 |
Why?
|
Insurance Carriers | 1 | 2011 | 159 | 0.020 |
Why?
|
Texas | 1 | 2010 | 410 | 0.020 |
Why?
|
Neurology | 1 | 2016 | 784 | 0.020 |
Why?
|
Age Factors | 2 | 2015 | 18380 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2016 | 81505 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 21501 | 0.020 |
Why?
|
Risk Factors | 2 | 2012 | 74853 | 0.020 |
Why?
|
Urban Health | 1 | 2010 | 530 | 0.020 |
Why?
|
Aluminum | 1 | 2007 | 150 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2011 | 65223 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2012 | 960 | 0.020 |
Why?
|
Cross Infection | 1 | 2015 | 1425 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2011 | 873 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2011 | 810 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2006 | 26337 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2011 | 1238 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5302 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2844 | 0.020 |
Why?
|
Self Report | 1 | 2016 | 3768 | 0.010 |
Why?
|
Episode of Care | 1 | 2005 | 128 | 0.010 |
Why?
|
Hyperlipidemias | 1 | 2010 | 770 | 0.010 |
Why?
|
Syndrome | 1 | 2010 | 3269 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10087 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8875 | 0.010 |
Why?
|
Prospective Studies | 2 | 2016 | 54798 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2005 | 12235 | 0.010 |
Why?
|
Parents | 1 | 2014 | 3590 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5873 | 0.010 |
Why?
|
Trust | 1 | 2004 | 532 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2010 | 2235 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2011 | 1936 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 4849 | 0.010 |
Why?
|
Pneumonia | 1 | 2011 | 2156 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2011 | 3051 | 0.010 |
Why?
|
Computer Simulation | 1 | 2011 | 6252 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9336 | 0.010 |
Why?
|
Information Dissemination | 1 | 2004 | 1140 | 0.010 |
Why?
|
Quality of Life | 1 | 2016 | 13466 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12520 | 0.010 |
Why?
|
Chronic Disease | 1 | 2005 | 9355 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2007 | 39226 | 0.000 |
Why?
|